We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Labeling Mix-Ups Lead to Consent Decree for Shamrock Medical
Labeling Mix-Ups Lead to Consent Decree for Shamrock Medical
September 20, 2013
Shamrock Medical Solutions Group has been barred from any continued drug repackaging and distribution services until it comes into compliance with current good manufacturing practices (cGMP), according to a consent decree approved by a federal judge Sept. 17.